National Cancer Institute. Dictionary of cancer terms. PARP-1 inhibitor AG014699.
Triple negative metastatic breast cancer: a phase 2, multi-center, Open-Label, Randomized Trial of Gemcitabine/carboplatin (G/C) with or without BSI-201, a PARP inhibitor. J. O'Shaughnessy, c. Osborne, j. Blum, j. Pippen, m. Yoffe, d. g. Patt, Monaghan, c. Rocha, v. Ossovskaya, b. Sherman and c. Bradley. SABCS Poster, December 2008.
Recombination repair and treatment of cancer BRCA genes. Helleday, Thomas, Arnaudeau, c., Lundin, c. nature 434, 913-7. (2005).